The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

When used with the appropriate medical guidance, GLP-1 medications like Ozempic, Wegovy and Mounjaro can be an effective ...

Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

When the Trump administration slashed foreign aid, it gutted a program that had reduced malaria deaths world wide. In ...

Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...

At Ford Field on Thursday, Amon-Ra St. Brown and the Detroit Lions (7-5) face Javonte Williams and the Dallas Cowboys (6-5-1) in a matchup featuring two of the brightest stars in the NFL, beginning at ...

Temporarily shutting down a "lazy eye" triggers a burst of neuronal activity that reverses the condition in animal experiments, a study shows. When you purchase through links on our site, we may earn ...

SAN FRANCISCO, Dec 1 (Reuters) - The Trump administration has agreed to take a stake in xLight - a startup seeking to develop free-electron lasers viewed as key to making faster computing chips. The U ...

Pluribus Episode 4, “Please, Carol,” took viewers and characters on yet another a wild ride. But this time, a hospital, needles, drugs, and lots of tears were involved. Pluribus Episode 4 spoilers ...

Cosentyx (secukinumab) comes as a subcutaneous injection under the skin or an intravenous (IV) infusion into a vein. Doctors may prescribe it to treat plaque psoriasis, psoriatic arthritis, and other ...

Valentino secured a 530-million-euro loan in 2024 Loan breach triggered banks' request for investor support Capital injection to be completed by December 10 MILAN, November 11 (Reuters) - Kering (PRTP ...

Patients hoping to get their hands on a cheaper copycat of Johnson & Johnson’s fading anti-inflammatory blockbuster Simponi may have to wait for a few months more, thanks to an FDA inspection this ...